Loading clinical trials...
Loading clinical trials...
Phase III Trial to Evaluate the Efficacy of Maintaining Hemoglobin Levels Above 120 g/l With Erythropoietin Versus Above 100 g/l Without Erythropoietin in Anemic Patients Receiving Concurrent Radiation and Cisplatin for Cervical Cancer
Conditions
Interventions
External Beam Radiation Therapy
Cisplatin
+2 more
Locations
1
United States
Gynecologic Oncology Group of Arizona
Phoenix, Arizona, United States
Start Date
August 1, 2001
Primary Completion Date
May 15, 2004
Last Updated
August 9, 2017
NCT05012111
NCT03520647
NCT05447442
NCT05639972
NCT06287268
NCT04645199
Lead Sponsor
Gynecologic Oncology Group
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions